News
4D-ACS trial investigators found that after placement of a drug-coated stent (DCS), the ... of 1-month dual antiplatelet therapy (DAPT) with prasugrel and aspirin, followed by reduced-dose ...
Hosted on MSN29d
Prasugrel Strategy Rolls Short DAPT and De-Escalation Into OneIn acute coronary syndrome (ACS), a prasugrel (Effient)-based antiplatelet ... 4D-ACS trial investigators found that after placement of a drug-coated stent (DCS), the incidence of net adverse ...
– For people who have heart failure with a normal heart rhythm, there seems to be little to no advantage of warfarin (an anticoagulant: a medicine which prevents blood clotting by blocking proteins) ...
Dual antiplatelet drug administration is recommended after percutaneous coronary intervention (PCI) stent placement. Although prasugrel, a newer P2Y12 inhibitor, reportedly suppresses cardiovascular ...
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly ...
Two common allergy medications could cause a severe reaction in some people who stop using it. The U.S. Food and Drug Administration (FDA) issued an alert related to cetirizine (Zyrtec ...
Hoff is the CEO of A-S Medication Solutions. Big pharmacies are in trouble. In March, Walgreens announced that it had reached a $10 billion buyout deal with private-equity firm Sycamore — a ...
1 Division of Cardiology, University of Florida College of Medicine - Jacksonville, Jacksonville, FL 2 Division of Cardiology, University of Florida - Shands Jacksonville, Jacksonville, FL Jose ...
Continuing high prices and demand for GLP-1 weight-loss drugs is creating lots of questions about the affordability of these drugs for U.S. healthcare consumers. For more than two years ...
Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic, Wegovy, and Zepbound—or spacing out doses longer than ...
Studies have shown the popular weight loss drugs known as GLP-1 agonists may be helpful for more than just curbing appetite — and new research is looking at their potential impact on cancer risk.
“It’s crazy,” she said of the ever-changing insurance landscape for weight-loss medications. “It’s absolutely insane to try to keep up with it all.” Across the country, doctors who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results